NIH-funded research NIH-funded research

Digital Contingency Management for Opioid and Alcohol Use Disorder care

Official title: Cultivating Recovery: A Pilot Study of Digital Contingency Management for Co-occurring Opioid and Alcohol Use Disorder

Funded at University of Michigan at Ann Arbor · NIH-11417268 · Data updated 2026-11-12

A pilot test of a smartphone-based contingency management program to help people with both opioid use disorder and alcohol use disorder stay in treatment and reduce drinking.

More Alcohol Use research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 20, 2024
Project endAugust 31, 2027
Funding year2026
Award (this year)$390,000
NIH project number5R34AA031870-03
Project IDNIH-11417268 on NIH RePORTER

Who could benefit from this research

Could help

Adults enrolled in Medicaid with co-occurring opioid use disorder and alcohol use disorder who are seeking treatment.

Less likely to help

Individuals without Medicaid coverage or without co-occurring OUD and AUD may not benefit from this specific program.

What this research studies

This project will test a digital contingency management approach delivered via mobile devices to Medicaid beneficiaries with co-occurring OUD and AUD. It includes analyzing Medicaid data to find the best care settings, forming an Advisory Board to plan real-world implementation, and a mixed-methods randomized pilot to evaluate feasibility, acceptability, and impact on opioid retention and alcohol abstinence. The study will compare digital CM to a wellness control and will gather feedback from participants and sites to inform a larger future trial. Exit interviews will help understand patient and provider experiences and barriers to adoption.

Why it matters

Potential benefit: If successful, this approach could improve treatment retention and reduce alcohol use, potentially lowering overdose risk for people with both OUD and AUD.

How similar studies have gone: Contingency management has shown benefits for substance use disorders, and digital delivery is a promising next step that is being explored in similar populations.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Coughlin, Lara Nicole — University of Michigan at Ann Arbor
  • Study coordinator: Coughlin, Lara Nicole

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.